Exploring mental health using stem cells Flashcards

1
Q

What are IPSCs?

A

Induced Pluripotent Stem Cells

  • capacity to generate different cell types: foetal and adult bodies
  • > nervous system, heart and circulatory systems, muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are pluripotent cells?

A

Cells with capacity to generate different cell types

  • foetal and adult bodies
  • > nervous system, heart and circulatory systems, muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which cells have an ephemeral (temporary) pluripotent property?

A

Inner cell mass cells, in the blastocyst

  • these cells are incredibly ephemeral
  • > their pluripotency only lasts a few days and never reappears during the entire life cycle
  • > hard to study
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which cells have a permanent pluripotent property?

A

Embryonic stem cells

  • derived directly from inner cell mass
  • permanent pluripotency
  • they can give rise to all different cell types that make up the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Who initiated the discovery of the biological basis for pluripotency?
What was his/her experiment?

A

John Gordon
> Used enucleated egg (nucleus destroyed with radiation) containing pluripotent cells of Frog A
> Implanted nucleus of Frog B into egg -> egg with transplanted nucleus
> Egg develops into tadpole -> clone of Frog B
-> pluripotent constructed cell

  • > Nucleus, even from fully differentiated cell, had all info. to generate an organism
  • > There are factors in the enucleated egg that, once combined, tell the nucleus that it has to start behaving as a pluripotent cell

=> Existence of factors in the cytoplasm of pluripotent cells that dictate pluripotency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who found the biological basis for pluripotency which led to the discovery of iPS cells?
What are the Yamanaka factors?

A

Shinya Yamanaka
> Suggested the factors must be gene products = proteins
-> List of 24 potential pluripotency factors

Takahashi and Yamanaka (2006, 2007)
> Step 1: Have an assay for pluripotency: a way to recognise he’d produced pluripotency in cell that weren’t pluripotent
- pluripotent cells always seem to have the Fbx15 gene active -> a reporter for pluripotency (if cells turn blue they’ve become pluripotent)
- transfection of fibroblasts with the 24 pluripotency factors
-> within these 24 factors are the important ones leading to pluripotency

> Step 2:

  • Repeated experiment several times, leaving a factor out each time
  • factors needed to induce pluripotency vs. factors not needed

> Step 3:
- Repeated experiment with the 10 remaining factors, sequentially leaving one out at a time

=> Yamanaka factors: Oct3/4, Sox2, KIf4, c-Myc

  • if he uses these 4 factors, he gets blue cells, believed to be pluripotent ; leaving out 2 of them, he doesn’t get blue colonies
  • > all of the 4 remaining factors are needed to generate pluripotent cells
  • > these 4 factors are sufficient on their own

> Step 4:

  • generate embryoid bodies with 3 germ layers: ectoderm, mesoderm, endoderm
  • it is still a hypothesis that the blue cells are pluripotent

> Step 5:

  • take fibroblasts that had been transduced with the 4 factors, grow them into embryoid bodies and show each germ layer is represented in the embryoid bodies
  • histological sections of mice confirmed the cells had contributed to creation of all different body tissues = iPSCs
  • fibroblasts transduced with the 4 factors, injected in blastocyst, significantly contributed to the formation of germ line -> made it possible to produce mice that were entirely derived from these

=> Generate a whole line of mice derived from those transduced fibroblasts which were indeed pluripotent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happened after Takahashi and Yamanka’s 2006 experiment on mouse (skin) fibroblasts?

A

> 2007: Takahashi and colleagues: human (skin fibroblasts)
> Onwards: Yamanaka’s procedure accepted worldwide
- changes to protocol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How was the generation of IPSC lines used for the study of childhood disorders?

A

iPS cells can be derived from any cell type in the body:

  • blood cell sample
  • urine sample
  • hair sample -> suitable for the study of childhood disorders (e.g. autism)

Hair keratinocytes

  • reprogramming with Yakamana factors (Oct3/4, Sox2, KIf4, c-Myc)
  • > iPS cell colonies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How to make iPS cells to create neurons?

A
  1. Collect sample: blood cells, urine, hair
  2. Reprograming using Yakamana genes (Oct3/4, Sox2, KIf4, C-Myc)
  3. You get iPS cell colonies
  4. iPS cell line
    - used in the study of brain development disorders
  5. Neural ‘rosettes’ - progenitor cells
  6. Neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which genes are the Yakamana factors?

A
  • Oct3/4
  • Sox2
  • KIf4
  • c-Myc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the cultured neuralisation timeline?

A

> Day 1: iPS cell lines

  • SMAD signalling pathway inhibition to induce the iPS cell lines to produce neuroepithelium
  • > add SMAD inhibitors to the culture of these induced pluripotent cells

> Day 21: neural ‘rosettes’
- progenitor cells that can do tissue histogenesis (compared to NSCs found in other contexts)
- proper polarised neuroepithelium -> cells are trying to make a two-dimensional neural tube
= two-dimensional cell culture (in vitro)

> Day 28 to 35: young neurons

> Day 35 to 53: mature neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is reassuring about the cultured neuralisation and iPSCs technology?

A

It is a slow process (53 days to get mature neurons)
- reassuring because it reproduces the timing and the differentiation processes that seem to underly human neural development

=> iPSCs allow us to look at human neural development in a cultural dish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is histogenesis?

A

Processes that begin with the generation of neuroblasts, to the morphological and biochemical differentiation of mature neurons in the cortical plate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is specific about the histogenesis of iPSCs?

A
  • If you allow cell development, the iPS cells try and undergo proper histogenesis
  • iPS cells have this capacity for histogenesis remarkably larger than any other neural developing systems in vitro
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why does the cultured in vitro differentiation process and neural development ceases after cerebral tissue is developed?

A

Lack of blood supply which does not exist in the culture dish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a cerebral organoid culture?

A

Cortical structure developed entirely from iPS cells growing in a culture dish

17
Q

What are the possible studies using iPSCs to address questions around the etiology of neurodevelopment disorders?

A

> Compare lines from patients and controls

> Induce mutations in iPSCs
- inducing genetic variation (genome editing) into cells in vitro: CRISPR-cas9 system ; ZNFs ; TALENs

> Study environmental risk factors

  • e.g. autism risk increases if the mother suffers from influenza during her first trimester
  • pro-inflammatory cytokines -> altered neurodevelopment
18
Q

What kind of assays / phenotypes are we going to run on iPSCs to detect differences?

A

> Gene expression

  • patients or controls
  • genetic mutations or exposure to environmental risk factors
  • study differences in expression during developement

> Physiological

  • iPS cells eventually become electrophysically active
  • they develop the channels and receptors commonly present in human neurons

> Morphogenetic
- compare histogenesis of iPSCs derived from patient cells vs. control cells

19
Q

How did Pasca and colleagues (2011) use iPSCs to study disease pathophysiology?

A

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy Syndrome
(caused by point mutation in CACNA1C and encodes a sub-unit of a calcium channel)
> Patients vs. controls in terms of neurons and behaviour of the calcium channel
> iPS cells showed a predicted phenotype: carry mutation we know is associated with the disease
> They tried to generate cortical neurons
> In the differentiated iPS cells, authors used different markers to know if they got the normal distribution of upper-layer vs. infragranular cortical neurons

  • > Neurons derived from Timothy syndrome iPS cells had a greater propensity to make upper-layer neurons, and reduced propensity to make lower-layer neurons
  • > Smaller proportion of the lower-layer cells showed expression of SATB2
  • these lower-layer cells take either one of 2 fates:
    1. Subcortically projecting neurons: project to subcortical brain regions
    2. Callosal projecting neurons (with SATB2-positive cells): project across the corpus callous to the cerebral cortex on the other hemisphere

=> Neurons from Timothy syndrome patients have a lower proportion of the SATB2-positive cells
- lower proportion of callosal projecting neurons

> Transgenic mouse engineered to carry the mutation found in Timothy syndrome

  • > same histogenic phenotype in the cortical structure of the mouse as seen in cells carrying the calcium channel mutation
  • > lower number of SATB2 positive cells in lower layer of cortex of the mouse compared to controls
20
Q

What are the advantages of cellular models of neurodevelopmental disorders?

A

> True human cells used
> Good construct validity
> Good controls
> Tractable system
> High through-put screening
> Able to be manipulated genetically and phenotypically

Genome editing makes it possible to remove particular mutations from cells
e.g. with CRISPR-cas9

21
Q

What are the disadvantages of cellular models of neurodevelopment disorders?

A

> Variability: genetic and epigenetic differences between individuals
- higher variability in human cells when compared to cells derived from mice, which can be genome controlled to become genetically identical

> System properties inaccessible
- disorders don’t concern the property of a single cell population, but of properties of the brain as a whole

> Slow development
- long wait required for the development of iPS cells is a disadvantage in terms of practicability and logistics

> No behaviour

  • iPS cells lack the behaviour phenotypes present in several neurodevelopment disorders (e.g. autism)
  • > to what extent the cellular and molecular phenotypes observed in culture actually relate to human behaviour

=> To observe behavioural changes, animal models are still needed